Keith Cummings's Insider Trades & SAST Disclosures
Keith Cummings's most recent trade in Pliant Therapeutics Inc was a trade of 113,300 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 23, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Keith Cummings.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 113,300 | 113,300 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 56,650 | 319,258 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 17 Jan 2025 | 20,148 | 262,608 | - | 11.2 | 225,680 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.56 per share. | 10 Jul 2024 | 10,911 | 282,115 | - | 11.6 | 126,131 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2024 | 21,313 | 293,026 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 21,000 | 76,047 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 02 May 2024 | 21,000 | 271,713 | - | 2.1 | 43,680 | Common Stock |
| Pliant Therapeutics Inc | Cummings Keith | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 110,500 | 110,500 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 55,250 | 249,855 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Cummings Keith | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.23 per share. | 17 Jan 2024 | 9,781 | 194,605 | - | 17.2 | 168,527 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 17 Jul 2023 | 19,771 | 203,999 | - | 18.0 | 356,058 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 38,750 | 223,770 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 09 Jun 2023 | 5,800 | 154,270 | - | 2.1 | 12,064 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2023 | 5,800 | 127,797 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.52 per share. | 30 Mar 2023 | 9,960 | 148,470 | - | 26.5 | 264,148 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 19,375 | 158,430 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 76,200 | 76,200 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 54,000 | 138,424 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 23 Jan 2023 | 30,000 | 84,424 | - | 35 | 1,050,000 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2023 | 17,500 | 18,198 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.22 per share. | 23 Jan 2023 | 17,500 | 114,424 | - | 6.2 | 108,850 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 23 Jan 2023 | 12,500 | 96,924 | - | 2.1 | 26,000 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2023 | 12,500 | 133,597 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 22 Dec 2022 | 4,000 | 84,424 | - | 2.1 | 8,320 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2022 | 4,000 | 146,097 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2022 | 19,375 | 90,067 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.10 per share. | 19 Dec 2022 | 9,643 | 80,424 | - | 19.1 | 184,204 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 124,000 | 124,000 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 05 Mar 2021 | 20,000 | 47,621 | - | 2.1 | 41,600 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 20,000 | 170,097 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2021 | 74,250 | 74,250 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 4,500 | 190,097 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 21 Dec 2020 | 4,500 | 27,621 | - | 2.1 | 9,360 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.21 per share. | 01 Dec 2020 | 14,901 | 23 | - | 30.2 | 450,159 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 01 Dec 2020 | 11,591 | 34,712 | - | 2.1 | 24,109 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 11,591 | 194,597 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.22 per share. | 01 Dec 2020 | 7,143 | 41,855 | - | 6.2 | 44,429 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 7,143 | 35,698 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 29.07 per share. | 01 Dec 2020 | 1,848 | 38,868 | - | 29.1 | 53,721 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 28.24 per share. | 01 Dec 2020 | 1,139 | 40,716 | - | 28.2 | 32,165 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.72 per share. | 01 Dec 2020 | 846 | 23,121 | - | 30.7 | 25,989 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 42,841 | 42,841 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 27,322 | 27,322 | - | - | Series C Preferred Stock | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | 05 Jun 2020 | 27,322 | 0 | - | - | Series C Preferred Stock | ||
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2020 | 19,300 | 206,188 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 05 Jun 2020 | 19,300 | 19,300 | - | 2.1 | 40,144 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | 05 Jun 2020 | 3,821 | 23,121 | - | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges